Cargando…

The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease

BACKGROUND: Recent publications have reported follow-up of the RTS,S/AS01 malaria vaccine candidate Phase III trials at 11 African sites for 32 months (or longer). This includes site- and time-specific estimates of incidence and efficacy against clinical disease with four different vaccination sched...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penny, Melissa A., Pemberton-Ross, Peter, Smith, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634589/ https://www.ncbi.nlm.nih.gov/pubmed/26537608 http://dx.doi.org/10.1186/s12936-015-0969-8

Ejemplares similares

Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S
por: Galactionova, Katya, et al.
Publicado: (2021)

RTS,S: the first malaria vaccine
por: Zavala, Fidel
Publicado: (2022)

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
por: Penny, Melissa A, et al.
Publicado: (2016)

RTS,S Malaria Vaccine and Increased Mortality in Girls
por: Klein, Sabra L., et al.
Publicado: (2016)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
por: Fortpied, Juliette, et al.
Publicado: (2020)

Resurgence of malaria infection after mass treatment: a simulation study
por: Smith, Thomas A., et al.
Publicado: (2019)

The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models
por: Penny, Melissa A, et al.
Publicado: (2015)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission
por: Brooks, Alan, et al.
Publicado: (2012)

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria
por: Olotu, Ally, et al.
Publicado: (2011)

The RTS,S malaria vaccine: Journey from conception to recommendation
por: Egbewande, Oluwaseyi Muyiwa
Publicado: (2022)

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania
por: Romore, Idda, et al.
Publicado: (2016)

Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model
por: Genito, Christopher J., et al.
Publicado: (2023)

Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination
por: Thompson, Hayley A., et al.
Publicado: (2020)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
por: Baral, Ranju, et al.
Publicado: (2023)

The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01(E) vaccination and seasonal malaria chemoprevention versus either intervention given alone
por: Cairns, Matthew, et al.
Publicado: (2022)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
por: Waitumbi, John N., et al.
Publicado: (2009)

Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination
por: Dobaño, Carlota, et al.
Publicado: (2019)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
por: Moris, Philippe, et al.
Publicado: (2017)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
por: Merle, Corinne S.
Publicado: (2023)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
por: Bell, Griffin J., et al.
Publicado: (2020)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
por: Arora, Navneet, et al.
Publicado: (2021)

Should India be considering deployment of the first malaria vaccine RTS, S/AS01?
por: Rahi, Manju, et al.
Publicado: (2022)

RTS,S/AS01 Malaria Vaccine - The Next Step for a Developing Country
por: ZEHRA, ASMAT, et al.
Publicado: (2022)

RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
por: Syed, Yahiya Y.
Publicado: (2022)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
por: Mumtaz, Hassan, et al.
Publicado: (2023)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

Age-shifting in malaria incidence upon cessation of interventions: a simulation study
por: Pemberton-Ross, Peter, et al.
Publicado: (2014)

The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection
por: Du, Ying, et al.
Publicado: (2020)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries
por: Sicuri, Elisa, et al.
Publicado: (2019)

Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial
por: Kurtovic, Liriye, et al.
Publicado: (2020)

Drivers of differences in expected public health impact of RTS,S in individual countries of Africa: an individual-based modeling study
por: Penny, Melissa, et al.
Publicado: (2014)

Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children
por: Feng, Gaoqian, et al.
Publicado: (2022)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study
por: Pemberton-Ross, Peter, et al.
Publicado: (2015)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

The Clinical Profile of Severe Pediatric Malaria in an Area Targeted for Routine RTS,S/AS01 Malaria Vaccination in Western Kenya
por: Akech, Samuel, et al.
Publicado: (2020)

The Relationship between RTS,S Vaccine-Induced Antibodies, CD4(+) T Cell Responses and Protection against Plasmodium falciparum Infection
por: White, Michael T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kvjocre8f47q7flfttf0d708u1